Company Registration No. 13123378 (England and Wales)
CYTOPHARMA LTD
Annual Report and Statement of Accounts
For the Period from 01 February 2023 to 31 July 2024

CYTOPHARMA LTD

Annual report and statement of accounts for the period ending 31/07/2024

CYTOPHARMA LTD

Financial statement for the period ended 31/07/2024

Company Information

1 Statutory Information
Company Number 13123378
Registered Office 198 WARREN ROAD
BRIGHTON
BN2 6DD
2 Directors
Directors who held office during the period were:
FREYBERG, Mark-Andre, Dr   
KAISER, Dirk, Dr   
3 Principal Activity
Research and experimental development on biotechnology
4 Employees
Average number of employees, including directors, during the year was as follows:
2024 2
2023 2

CYTOPHARMA LTD

Financial statement for the period ended 31/07/2024

Statement of Financial Position

2024 2023
£ £
Fixed Assets 1,700 -
Current Assets 143 34,590
Prepayment and accrued Income - 12,000
Creditors: amounts falling due within one year (2,856) -
Net Current Assets (2,713) 46,590
Total assets less current liabilities (1,013) 46,590
Creditors: amounts falling due after one year - -
Net Assets (1,013) 46,590
Capital and reserves (1,013) 46,590
For the period ending 31/07/2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Approved by the Board on 04 August 2024
Dr Mark Andre Freyberg
Company Registration No. 13123378